Pricing Log in Create free account

Dyne Therapeutics, Inc. (DYN) vs IDEAYA Biosciences, Inc. (IDYA)

Dyne Therapeutics, Inc. and IDEAYA Biosciences, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and IDEAYA Biosciences, Inc. are of similar size ($3.2B and $3.0B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −1,149.6%) and the lower return on invested capital (−1,956.3% vs −114.2%). Across the 14 metrics below, IDEAYA Biosciences, Inc. leads on 9 and Dyne Therapeutics, Inc. on 5.

Valuation

Metric DYN IDYA Biotechnology median
P/E n/m n/m 10.26
P/S n/m 86.70 9.18
P/B 4.13 2.90 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 63.75 8.98
Earnings yield (19.00%) (14.60%) (34.89%)
Free cash flow yield (16.56%) (11.04%) (24.52%)

Profitability

Metric DYN IDYA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,267.38%) 0.00%
Net margin 0.00% (1,149.62%) 0.00%
Free cash flow margin 0.00% (957.43%) 0.00%
Return on equity (81.57%) (38.46%) (50.12%)
Return on assets (60.29%) (34.98%) (45.60%)
Return on invested capital (1,956.27%) (114.15%) 0.00%

Growth

Metric DYN IDYA Biotechnology median
Revenue growth (TTM) — (83.64%) 6.26%
EPS growth (last fiscal year) (2.97%) 61.90% 29.88%
Revenue growth, 5-year CAGR — 62.11% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYN IDYA Biotechnology median
Debt to equity 0.30 0.00 0.00
Current ratio 12.02 9.04 4.89
Net debt to EBITDA 2.05 3.88 1.01

Dividend

Metric DYN IDYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DYN IDYA Biotechnology median
Market cap 3.24b 2.96b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack